Introduction
Recruitment of T lymphocytes to sites of viral replication is of vital importance in the development of the inflammatory reaction by which the termination of the infection is normally achieved. Therefore, analysis of virus-induced T cell-mediated inflammation is likely to provide essential insight into the pathogenesis of viral diseases. A classical model for such studies is the murine lymphocytic choriomeningitis virus (LCMV) infection. In adult immunocompetent mice infected with LCMV, the inflammatory exudate consists mainly of CD8 + T cells and monocyte/macrophages, the former of which is the key effector population in this infection (1,2). While some parts of the cascade of events underlying the formation of this cellular exudate are well understood, others are still obscure. Thus, in previous reports we have demonstrated that LCMV infection induces the generation in the spleen of an activated CD8 + T cell population with a characteristic profile of adhesion molecule expression (VLA-4 hl LFA-1 hl Lselectin'°Pgp-1 hl Mac-1 + ) from which cells at sites of infection appear to be recruited (3-6). Moreover, mAb to several of these adhesion molecules have been shown to block the localization of T cells to infected organs (4-6), indicating that the regulation of adhesion molecule expression constitutes a pivotal element in targeting virus-primed T cells to sites of infection. Consistent with this assumption we have recently found that the corresponding vascular ligands (ICAM-1 and VCAM-1) are up-regulated on endothelium in and near sites of infection, and that this up-regulation in itself depends on the presence of activated T cells, as it is absent in T celldeficient nude mice (7). On the other hand, the cytokines involved have not been characterized. Therefore, to expand our understanding of the regulatory events underlying virusinduced T cell-mediated inflammation, the present study was undertaken to analyze the cytokine production profile of LCMV-primed T cells in the spleen and the inflammatory exudate, and to phenotypically identify the producing cells. Traditionally, much attention has been focussed on CD4 + T cells as producers of a wide variety of cytokines (8) whereas CD8 + 
T cells, particularly in the context of viral infections, + T cells with a type 1 cytokine profile
have been considered primarily cytotoxic effectors (9-11). However, it has long been known that cloned CD8 + cytotoxic T lymphocytes (CTL) may release cytokines like IFN-y (12-14) and recent reports suggest that CD8 + T cells play an active role in the regulation of the immune response through their release of cytokines (15,16). Using short-term stimulation with anti-CD3 antibody as our test system, we show here that CD8 + T cells of LCMV-infected animals are primed to function not only as cytotoxic cells, but also as potent producers of IFN-y, but not tumor necrosis factor (TNF)-a, IL-5 or IL-10. Furthermore, this potential for cytokine production is predominantly a quality of a subset of T cells targeted for migration to inflammatory sites, i.e. VLA-4 hl L-selectin l0 , and an increased level of surveillance by these cells is maintained for several months after virus inoculation.
Methods

Mice
BALB/cA and C57BL/6 mice were obtained from Bomholtgaard (Fty, Denmark). Female mice, 7-10 weeks old, were used in all experiments, and the animals were always allowed to acclimatize to the local environment for at least 1 week before use. Animals were housed under controlled conditions that included testing of sentinels for unwanted infections; no such infections were detected.
Virus
LCMV of the Traub strain, produced and stored as previously described (17) , was used throughout the experiments. Mice to be infected received a virus dose of 10 3 LDso in an i v. or in some cases i.p injection of 0 3 ml. Infection by these routes is followed by transient immunizing infection, whereas intracerebral infection induces a fatal T cell-mediated meningitis (1,3).
Treatment with hydroxyurea
Mice infected 6 days earlier were treated twice with 25 mg i.p. 6 h apart. This treatment results in marked inhibition of T cell activation as evaluated both phenotypically and functionally (6).
Cell preparations
Spleens were removed from mice killed by ether anesthetization. Single-cell suspensions were obtained by pressing the organs through a fine steel mesh and when used for analysis by flow cytometry, erythrocytes were lysed by 0 83% NH 4 CI treatment. Peritoneal exudate cells (PEC) were obtained by lavage with 5 ml of cold HBSS containing 5 ILJ/ml heparin (4). Unless otherwise specified, cells to be analyzed were always pooled from at least three animals.
mAb for flow cytometry
The following mAb were all purchased from PharMingen (San Diego, CA) as rat anti-mouse antibodies: FITC-conjugated anti-CD49d (common a-chain of LPAM-1 and VLA-4) (lgG2b), FITC-, Cy-chrome-and phycoerythrin (PE)-conjugated antiCD8a (lgG2a), PE-conjugated anti-CD4 (lgG2a), PE-conjugated anti-CD44 (Pgp-1) (lgG2b), FITC-conjugated anti-CD62L (L-selectin, MEL-14) (lgG2a), PE-conjugated anti-IL-5 (lgG1), and PE-conjugated anti-IFN-y (lgG1).
Flow cytometry
Staining for double-color immunofluorescence was performed by incubating 1x10 6 cells in individual wells of a 96-well round-bottom microtiter plate for 5-10 min in a FACS medium containing 10% rat serum, 1% BSA and 0.1% NaN 3 in PBS. Then cells were incubated with relevant antibodies in the dark for 30 mm at 4°C. After incubation, cells were washed three times with 0.1% NaN 3 in PBS and fixed with 1% cold paraformaldehyde in PBS (3-6).
Staining for intracellular cytokines was performed by incubating 1 x 10 6 cells in individual wells of a 96-well round-bottom microtiter plate in staining buffer (1% FCS and 0.1% NaN 3 in PBS) with relevant antibodies for cell surface antigens in the dark for 30 min at 4°C. Cells were washed twice in staining buffer and resuspended in fixation buffer (4% paraformaldehyde in PBS) in the dark for 20 min at 4°C. Then cells were washed in staining buffer, resuspended in permeabilization buffer (1% FCS, 0.1% NaN 3 and 0.5% saponin in PBS) and incubated with relevant cytokine-specific antibodies for 30 min at 4°C Cells were washed in permeabilization buffer and resuspended in staining buffer.
Fractionation of cells
Splenocytes were sorted using a Becton Dickinson FACStar Plus (3,5). Postsort analyses were performed to determine sort purity; the purity of all populations were >90%
Cell depletion
In order to deplete CD4 + , CD8 + or all T cells, spleen cells were incubated in vitro with anti-L3T4, anti-Ly-2.2 or antiThy-1.2 mAb and Low-Tox-M rabbit complement (Cederlane Laboratories, Hornby, Ontario, Canada) according to the protocol recommended by the manufacturer. Cells incubated with complement alone served as control. After washing, cells were resuspended to their original volumes in complete cell culture medium and diluted accordingly (4).
Induction of cytokine release in vitro
In order to evaluate the total potential of T cells to produce cytokines, in vitro stimulation with anti-CD3 was carried out. Unless otherwise specified, cell were stimulated for 6 h using soluble anti-CD3e (18) at a final concentration that has previously been found to induce maximal proliferation (data not shown). In experiments involving overnight incubation, plate-bound anti-CD3e (25 ng/ml; PharMingen) was used (19) . Following incubation, supernatants were harvested and stored at -70°C until analysis.
Quantitation of released cytokines
All cytokine concentrations were measured using sandwich ELISAs. The following ELISA kits were used in this study: IFN-y, TNF-a, IL-5 (Endogen, Cambridge, MA) and IL-10 (Genzyme, Cambridge, MA). All assays were run according to manufacturer's instructions, and cytokine levels were calculated by comparison with standard curves generated using recombinant cytokines; the limits of cytokine detection were. a Splenocytes (2xiO 5 /well) were incubated with or without anti-CD3 for 6 h at 37°C Duplicate cultures were assayed and medians are presented, each experimental group was tested at least twice with similar results 15 pg/ml (IFN-y), 1 5 pg/ml (TNF-a), 5 pg/ml (IL-5) and 15 pg/ ml (IL-10).
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Redirected killing
A redirected CTL assay using FcR-bound mAb to CD3e (20) was used to detect all CD3 + T cells with activated lytic machinery. Target cells were FcR + P815 cells. Unless otherwise specified, the assays were incubated for 6 h at 37°C and results are expressed as specific 51 Cr release (17)
Results
LCMV infection induces effector T cells with a type 1-like cytokine profile
To determine the capacity of in wVo-activated splenic T cells to produce cytokines at the time when seeding of effector cells to infected organs occurs (3,21), spleen cells from mice infected with LCMV 7 days earlier were stimulated for 6 h with anti-CD3 This regimen of stimulation was chosen based on two considerations. First, anti-CD3 stimulation is thought to resemble physiological stimulation and would at the same time act to trigger cytokine release from all activated T cells, and not only those that are LCMV-specific-which is important given the extensive by-stander activation previously demonstrated (22, 23) . Second, short-term stimulation was chosen to clearly differentiate in vivo generated effector cells from naive cells being activated in vitro and to minimize confounding cellular cooperation in vitro that might hamper the identification of cytokine producing effectors.
As can be seen in Table 1 , stimulation of 7-day primed splenocytes with anti-CD3 induced rapid release of high amounts of IFN-y, whereas little or no IL-5 or IL-10 was detected. Only low production of IFN was noted from similarly stimulated spleen cells from uninfected controls. Low levels of spontaneous release of this cytokine were also detected in unstimulated cultures from infected animals, but not from uninfected controls. Notably, the same cytokine release profile was observed in C57BL/6 mice and in BALB/c mice which represent genotypes with a propensity to produce either a predominant type 1 or type 2 cytokine profile respectively in response to other stimuli (24) . The production of TNF-a was also evaluated and low amounts were generally detected; however, the levels varied independently of anti-CD3 stimulation indicating that this was not predominantly a T cell product Finally, to exclude that failure to detect certain cytokines could simply be a reflection of the short stimulation period chosen, we also assayed supernatants harvested after 12 and 24 h of in vitro culture. No IL-5 was detected and only low amounts of IL-10 (-50-100 pg/ml). However, as the levels of IL-10 tended to be higher in cultures not stimulated with anti-CD3, this is not likely to reflect production by T cells.
Effector T cells with a type 1-like cytokine profile are found at inflammatory sites
To evaluate the potential of inflammatory T cells to produce cytokines, BALB/c mice were infected i.p. and PEC were harvested on day 9 post-infection At this time point a cellular exudate is found which is dominated by CD8 + T cells with an activated phenotype, i.e. VLA-4 hl (data not shown). Stimulation of these cells with anti-CD3 yielded a cytokine profile similar to that observed for spleen cells: production of IFN-y, but no or marginal amounts of IL-5, IL-10 or TNF-a (Table 2) ; furthermore, the capacity to produce IFN-y was markedly augmented compared to that by spleen cells from the same animals
Capacity of LCMV-activated 7cells to produce IFN-y correlates with other parameters of anti-viral cell-mediated immunity
To study the kinetics of effector T cells with capacity to produce IFN-y, BALB/c mice were infected with LCMV i.v. and on days 3, 7, 10, 17 and 50 post-infection spleen cells were harvested and stimulated in vitro for 6 h. The results of this analysis (Fig. 1) revealed that little or no augmentation of IFN-y production was observed with 3-day primed splenocytes whereas cells taken from animals infected 7-10 days earlier released high amounts of IFN-y upon in vitro stimulation; lower, but still significant amounts compared to uninfected controls, were produced on day 17 and even on day 50 postinfection This is essentially the same pattern found previously for LCMV-specific CTL (17) . Moreover, augmented release of IFN-y is temporally associated with the appearance and continued presence of CD8 + T cells with an effector/memory phenotype as described recently (3,6). Finally, treatment with hydroxyurea previously shown to inhibit the clonal expansion + T cells with a type 1 cytokine profile "Splenocytes and PEC were incubated in microwells (200 ul) with or without anti-CD3 for 6 h at 37°C. Duplicate cultures were assayed and medians are presented, each experimental group was tested twice with similar results of activated T cells (6) markedly inhibited the appearance of T cells with the capacity to release IFN-y (>75% inhibition; data not shown). Notably, production of IFN-ydid not correlate with anti-CD3 induced proliferation (Fig. 1) , demonstrating that increased cytokine release was not a consequence of a generally increased responsiveness to stimulation.
IFN-y is predominantly produced by CD8 + T cells
To identify the T cell subset(s) primed to produce IFN-y, spleen cells from day 7 infected animals were depleted of CD4 + , CD8 + or Thy-1 + cells before stimulation with anti-CD3. As expected, elimination of all T cells using anti-Thy-1 and complement completely abolished the production of IFN-y (Fig 2A) , validating that indeed the result of T cell priming is investigated Depletion of CD4 + cells only marginally reduced the production, whereas elimination of CD8 + cells was almost as effective as anti-Thy-1 treatment. Since this pattern of a predominant CD8 + cell-dependent production could simply have reflected the numerical dominance of these cells in the spleen at this time of infection, and not the potential of the individual cell, a second experiment was carried out in which the productive capacity of sorted CD4 + and CD8 + cells were compared. As can be seen in Fig. 2(B) , pure T populations were also able to respond to short-term stimulation with anti-CD3, although the absolute levels measured were somewhat lower compared with unsorted cells than might be expected from the enrichment obtained; this probably reflects that there are no adherent cells to enhance presentation of anti-CD3 in this case. More important, CD8 + cells were found to be ~4-fold more efficient producers of IFN-y than CD4 + cells, indicating that the frequency of activated cells and/or the production per activated cell was higher within the former T cell subset.
Phenotypic characterization of IFN-y-producing CD8 + T cells
To characterize the subtype of CD8 + T cells primed for production of IFN-y, splenic CD8 + T cells were sorted into VLA-4 hl and VLA-4 10 cells, and then stimulated with anti-CD3. Analysis of IFN-y production revealed that CD8 + VLA-4 hi cells were at least 4-fold more efficient producers of IFN (Fig. 3A) . Corresponding results (Fig. 3B) were obtained when splenic CD8 + cells were sorted based on expression of L-selectin [previous studies have established a reciprocal pattern of expression of VLA-4 and L-selectin on LCMV-activated T cells (3)] thus excluding that the augmented release of IFN-y simply reflects anti-VLA-4-mediated co-stimulation enhancing cytokine production. Since LCMV-specific CTL belong to the same phenotypic subset (3,6), these findings suggest that cytokine production and cytolysis is mediated by the same subset of LCMV-activated T cells. However, LCMV infection is known to cause generation of CTL with specificities other than LCMV (22, 23) . Therefore, before assigning all LCMVinduced effector capacity to this subset, it had to be excluded that CTL were induced which would not be included in the above defined subset. Therefore, sorted cells were also tested using a redirected killing assay to reveal all CTL irrespective of TCR specificity. This analysis (data not shown) yielded results similar to those previously obtained for LCMV-specific CTL. Thus, all LCMV-induced effector capacity was confined to a single subset of CDS+VLA^L-selectin 10 cells. 
Frequency of IFN-y-producing cells
The above results phenotypically characterize the dominant IFN-y-producing T cell subset in LCMV-infected mice. However, no information is obtained concerning the frequency of these cells Therefore, presence of intracellular cytokine was analyzed in combination with surface immunophenotype. Following stimulation for 6 h with anti-CD3, -50% of splenic CD8 + VLA-4 hl cells in day 8 LCMV-infected mice were positive for presence of IFN-y (Fig. 4) . This is in contrast to CD8 + cells from unprimed mice in which <10% were positive. Considering that the frequency of CD8 + cells is increased 3-fold in the infected mice, this represent -9-fold increase in the frequency of IFN-y-producing cells. To ascertain the specificity of the staining reaction an isotype-matched antibody to IL-5 was included as control; in agreement with the absence of IL-5 in the supernatant of stimulated cultures, no positive cells were found. Notably, anti-CD3 stimulation was required to detect IFN-y-producing cells indicating that although the cells were primed for production of this cytokine, protein synthesis was limited without stimulation through the TCR.
Long-term priming of CD8 + T cells in LCMV-infected mice
As seen in Fig. 1 , T cells from mice infected as much as 2 months earlier still showed evidence of augmented IFN-y release upon short-term stimulation in vitro. This was also apparent if the stimulation period was extended to 12-24 h, at which time LCMV-primed cells produced ~3-to 10-fold more IFN-y than did unprimed controls (data not shown).
Comparison of overnight induced IFN-y production by sorted CD4 + and CD8 + cells from late LCMV-infected mice and from uninfected controls revealed substantial priming by LCMV of CD8 + cells only (Fig. 5A) . Phenotypically, CD8 + cells of late LCMV-infected mice are characterized by a high frequency of VLA-4 W and L-selectin to cells which are also Pgp-1 w (6). Since expression of this latter marker has previously been t> Day 8 + anti-CD3 found to segregate with capacity to produce IFN-y (19,25) , we analyzed the levels of IFN-y production by LCMV-primed CD8 + Pgp-1 hi and CD8 + Pgp-1 to cells following overnight stimulation (Fig. 5B.) . This experiment clearly established that within the CD8 + subset of LCMV-primed mice, only Pgp-1 hl cells were primed for production of IFN-y. A similar pattern was found with regard to redirected killing evaluated in a 12 h assay (Fig. 6 ) Therefore, the long-standing increase in the number of CD8 + Pgp-1 hl cells signifies an increased level of T cell surveillance in LCMV-infected mice.
Discussion
In the present study we have used polyclonal stimulation with anti-CD3 to study the effect of a systemic virus infection on the capacity of T cells to produce cytokines This approach permits evaluation not only of virus-specific T cells, but also of bystanders activated as a consequence of the infection (3, 22, 23) . Following LCMV infection, T cells are generated which can be induced to rapidly release high amounts of IFN-Y, but not IL-5, IL-10 or TNF-a. Since transcript induction in naive cells generally requires at least 6-12 h of stimulation, our demonstration of substantial production within a 6 h period of in vitro culture with levels reaching a plateau at 12-24 h (unpublished observation), indicate that most of these cells represent in vivo differentiated effector cells of physiological relevance. The observation that cytokine release is virtually inversely correlated with capacity to proliferate is consistent with this interpretation as is the correlation between serum Although viral infections are often taken to be associated with a type 1 cytokine profile, the evidence supporting this assumption is mostly indirect, based on the isotypic bias of the antiviral antibody response-predominantly lgG2a antibodies (27) (28) (29) which have been demonstrated to be positively regulated by IFN-y (30) . Indeed, when direct analysis of the cytokine profile has been carried out, a different picture often emerges. Thus, studies in influenza and Sindbis virus infected mice have revealed concurrent appearance of both type 1 and type 2 cytokines (31, 32) , and in the murine AIDS model a shift from an initially mixed profile to a later type 2 pattern is observed (33) . Moreover, the cytokine profile may vary depending on the anatomical compartment evaluated as illustrated by studies in mice with HSV-induced keratitis (34) .
In this study we find that systemic infection with a natural murine pathogen induces a T cell response with an extreme bias for the type 1 cytokine IFN-y relative to the type 2 cytokines IL-5 and IL-10. Further it is evident that CD8 + cells, not CD4 + cells, are the major producers. This latter observation may explain recent findings in pymicroglobulin deficient mice which surprisingly have an impaired antibody response to vaccinia virus (35) . It is pertinent that CD8 + cells primed for cytokine production express a characteristic phenotype previously found to be associated with capacity to migrate to inflammatory sites (2-6). Since a similar cytokine profile is found analyzing cells taken directly from an inflammatory focus, our results support earlier indications that IFN-y-producing CD8 + T cells are crucially involved in the development of LCMV-induced inflammation. Thus it is a classical observation that CD8 + T cells are the major inducers of LCMV-specific delayed-type hypersensitivity (36) (37) (38) and
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IFN-y is present in high amounts in the cerebrospinal fluid of immunocompetent mice infected intracerebrally (26) . Given the capacity of IFN-yto induce up-regulation of ICAM-1, and also to some extent VCAM-1 (39, 40) , the production of this cytokine by the first activated T cells to arrive at a site of infection would explain the increased expression of these vascular adhesion molecules on the local endothelium which we have recently demonstrated to be mediated predominantly by CD8 + cells (7). In the absence of substantial non-specific monokine production (41) , this would constitute an essential element in directing effector cells to the infected area and allow the formation of a cellular exudate (42) Previous studies have shown that
cells constitute >75% of the already expanded CD8 + population found in the spleen of LCMV-infected mice, and although this subset has been found to contain all virus-specific cytotoxic cells (3,6), it is unlikely that this activity alone can explain such high numbers of cells. Thus during the acute response the frequency of LCMV-specific CTLp is in the order of 1/100 and ~2 months later 1/1000-2000 (43, 44) . However, functional studies have previously demonstrated that polyclonal induction of effector cells takes place in LCMV-infected mice (22, 23, 45, 46) resulting in generation of effector cells with low, if any affinity for LCMV (44) . By demonstrating that all effector capacity induced by this infection is confined to the above population, our results provide a phenotypic correlate for these earlier findings and suggest that the observed phenotypic changes are associated with differentiation towards effector cell status At present we do not know the physiological significance-nf any-of these non-specifically activated T cells. However, since bystander activation appears to be commonly associated with viral infections (47) , it is reasonable to assume that it is a phenomenon of biological relevance. Therefore, in view of the effector potential of these cells and their predisposition to migrate into inflammatory foci, it could be suggested that they somehow participate in amplification of T cell-mediated inflammation (48, 49) and in this manner help the smaller subset of antigen-specific T cells in clearing the infection. Neutralization of IFN-yhas previously been found to markedly reduce the antiviral capacity of LCMVprimed splenocytes in vivo (50, 51) .
Notably, augmentation of CD8
+ effector cell function is found to persist for a relatively long period in LCMV-infected mice. This is consistent with earlier findings strongly indicating that ongoing immune surveillance is required to permanently control this infection (38, 52) . The augmentation of effector cell capacity is associated with accumulation of CD8 + Pgp-1 W cells. A similar pattern has recently been found in aged mice which have not been subject to deliberate infection (19) . The mechanism driving the age-dependent shift in T cell phenotype is not known, but the present results strongly support the idea that the immune repertoire of old individuals to a large extent is shaped through previous encounters with infectious agents, e g. viruses (53) .
In conclusion, our studies have revealed marked and longstanding perturbation of the CD8 + subpopulation in mice infected with LCMV, and a subset of CD8 + cells has been characterized which phenotypically and functionally appears to represent primed cells equipped with potent effector potential.
